LoginSignup
Dermapharm Hldg logo

Dermapharm Hldg

Stock
Stock
ISIN: DE000A2GS5D8
Ticker: DMP
DE000A2GS5D8
DMP

Price

Price

Historical dividends and forecast

All dividend data

Dermapharm Hldg has so far distributed $0.946 in 2024. The next dividend will be paid on 02.07.2025

$1.166

CHART BY

Frequently asked questions

What is Dermapharm Hldg's market capitalization?

The market capitalization of Dermapharm Hldg is $2.12B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Dermapharm Hldg's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Dermapharm Hldg is 22.32. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Dermapharm Hldg?

Dermapharm Hldg's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.76. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Dermapharm Hldg's stock?

Currently, 5 analysts cover Dermapharm Hldg's stock, with a consensus target price of $50.42. Analyst ratings provide insights into the stock's expected performance.

What is Dermapharm Hldg's revenue over the trailing twelve months?

Over the trailing twelve months, Dermapharm Hldg reported a revenue of $1.21B.

What is the EBITDA for Dermapharm Hldg?

Dermapharm Hldg's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $320.97M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Dermapharm Hldg?

Dermapharm Hldg has a free cash flow of $114.96M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Dermapharm Hldg's stock?

The 5-year beta for Dermapharm Hldg is 0.95. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Dermapharm Hldg have, and what sector and industry does it belong to?

Dermapharm Hldg employs approximately 3,603 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Dermapharm Hldg's shares?

The free float of Dermapharm Hldg is 17.37M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $2.12B

5Y beta

 0.95

EPS (TTM)

 $1.76

Free Float

 17.37M

P/E ratio (TTM)

 22.32

Revenue (TTM)

 $1.21B

EBITDA (TTM)

 $320.97M

Free Cashflow (TTM)

 $114.96M

Pricing

1D span
$38.66$39.71
52W span
$32.55$47.74

Analyst Ratings

The price target is $50.42 and the stock is covered by 5 analysts.

Buy

5

Hold

0

Sell

0

Information

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.

3,603

Biotechnology & Drugs

Health Care

Identifier

ISIN

DE000A2GS5D8

Primary Ticker

DMP

Knockouts

Join the conversation
Sign upLogin